Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parmiani

Showing results (241-250 of 301) with videos related to

Pageof 31
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion moleculesF Arienti, C Gambacorti-Passerini, L Borin, et al.
European Journal of Immunology|May 16, 1998
Immunogenicity of the ALLAVGATK (gp100[17-25]) peptide in HLA-A3.1 melanoma patientsC Castelli, A Mazzocchi, F Rini, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotypeL Rivoltini, F Arienti, A Orazi, et al.
Experimental and Clinical Immunogenetics|January 1, 1987
Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activityC Traversari, G Ferrari, L Grazioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigensC Castelli, P Tarsini, A Mazzocchi, et al.
European Journal of Immunology|August 1, 1985
Disulfide-linked surface molecules of monoclonal antigen-specific suppressor T cells: evidence for T cell receptor structuresD Ballinari, C Castelli, C Traversari, et al.
Natural Immunity|March 1, 1994
Cytokine gene transduction in tumor cells: interleukin (IL)-2 or IL-4 gene transfer in human melanoma cellsC Melani, C Chiodoni, F Arienti, et al.
International Journal of Cancer|February 20, 1991
Activation of ras oncogenes and expression of tumor-specific transplantation antigens in methylcholanthrene-induced murine fibrosarcomasG Carbone, M G Borrello, A Molla, et al.
Journal of Immunogenetics|April 1, 1986
Loss of polymorphic restriction fragments of class I and class II MHC genes in a malignant melanomaG Angelini, G Fossati, P Radice, et al.
Tumori|December 31, 1991
Effect of prolonged subcutaneous administration of interleukin-2 on the circadian rhythms of cortisol and beta-endorphin in advanced small cell lung cancer patientsS Spinazzé, S Viviani, P Bidoli, et al.
Pageof 31

Showing results (241-250 of 301) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion moleculesF Arienti, C Gambacorti-Passerini, L Borin, et al.
European Journal of Immunology|May 16, 1998
Immunogenicity of the ALLAVGATK (gp100[17-25]) peptide in HLA-A3.1 melanoma patientsC Castelli, A Mazzocchi, F Rini, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotypeL Rivoltini, F Arienti, A Orazi, et al.
Experimental and Clinical Immunogenetics|January 1, 1987
Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activityC Traversari, G Ferrari, L Grazioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigensC Castelli, P Tarsini, A Mazzocchi, et al.
European Journal of Immunology|August 1, 1985
Disulfide-linked surface molecules of monoclonal antigen-specific suppressor T cells: evidence for T cell receptor structuresD Ballinari, C Castelli, C Traversari, et al.
Natural Immunity|March 1, 1994
Cytokine gene transduction in tumor cells: interleukin (IL)-2 or IL-4 gene transfer in human melanoma cellsC Melani, C Chiodoni, F Arienti, et al.
International Journal of Cancer|February 20, 1991
Activation of ras oncogenes and expression of tumor-specific transplantation antigens in methylcholanthrene-induced murine fibrosarcomasG Carbone, M G Borrello, A Molla, et al.
Journal of Immunogenetics|April 1, 1986
Loss of polymorphic restriction fragments of class I and class II MHC genes in a malignant melanomaG Angelini, G Fossati, P Radice, et al.
Tumori|December 31, 1991
Effect of prolonged subcutaneous administration of interleukin-2 on the circadian rhythms of cortisol and beta-endorphin in advanced small cell lung cancer patientsS Spinazzé, S Viviani, P Bidoli, et al.
Pageof 31